🇺🇸 FDA
Patent

US 11576948

Long-acting VEGF inhibitors for intraocular neovascularization

granted A61KA61K38/179A61K39/001109

Quick answer

US patent 11576948 (Long-acting VEGF inhibitors for intraocular neovascularization) held by The Regents of the University of California expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/179, A61K39/001109, A61K9/0019, A61K9/0048